It is finally here a large company has applied to US authorities. For the emergency approval of their COVID 19 vaccine. This is after a number of trials. That yielded them an above 94% efficacy. The trials results state that it is especially effective for older people. There are also results which are equally effective on children. Although there are still hurdles to overcome. Such as the requirement to keep the vaccine under very cold temperatures. This allows for the vaccine to be transported and distributed. Without affecting its efficacy rates. However, this has caused a scramble for dry ice. It is hoped if this approval is granted vaccines will be ready by mid to end of December.

The plan is to make it to the vulnerable in society and those working in close contact with affected people.

Previous articleTreasury Secretary Demands Remaining Funds From Cares Act Be Returned
Next articlePeople Choosing to Travel During The Holidays
Timothy is the Senior Editor for America Tonight with more than 20 years in media. Curiously enough, he started off within agricultural journalism (he's from Georgia, after all), but soon moved from articles about peaches to something more intense. He attended the University of Central Florida, receiving a bachelor's degree in Social Sciences and minoring in Crime, Law, and Deviance. At first he took a job as a traffic reporter (mostly to conquer his fear of heights, he claims), but after a month of relatively peaceful work was asked to cover a live police car chase. This was a game-changer: by the end of the same year he was leading the newsroom. Tim also loves to promise that he's quitting "next year", moving from New York to New Zealand and becoming a writer, but we don't believe him. He loves us too much.


Please enter your comment!
Please enter your name here